Environmental toxicants causing ovarian disease across generations

May 4, 2012 in Cancer

Washington State University researchers have found that ovarian disease can result from exposures to a wide range of environmental chemicals and be inherited by future generations.

WSU reproductive biologist Michael Skinner and his laboratory colleagues looked at how a fungicide, pesticide, plastic, dioxin and hydrocarbon mixtures affected a gestating rat's for multiple generations. They saw subsequent generations inherit ovarian disease by "epigenetic transgenerational inheritance." regulates how genes are turned on and off in tissues and cells. Three generations were affected, showing fewer ovarian follicles—the source of eggs—and increased polycystic ovarian disease.

The findings suggest ancestral environmental exposures and epigenetics may be a significant added factor in the development of ovarian disease, says Skinner.

"What your great grandmother was exposed to when she was pregnant may promote ovarian disease in you and you're going to pass it on to your grandchildren," he says. "Ovarian disease has been increasing over the past few decades to effect more than 10 percent of the human female population and environmental epigenetics may provide a reason for this increase."

The research appears in the current issue of the online journal PLoS ONE. It marks the first time researchers have shown that a number of different classes of environmental toxicants can promote the epigenetic inheritance of ovarian disease across multiple generations.

Research by Skinner and colleagues published earlier this year in PLoS ONE showed jet fuel, , plastics, and the pesticides DEET and permethrin can also promote epigenetic inheritance of disease in young adults across generations.

The work is a departure from traditional studies on several fronts. Where most genetic work looks at genes as the ultimate arbiters of inheritance, Skinner's lab has repeatedly shown the impact of the environmental epigenetics on how those genes are regulated. The field is already changing how one might look at toxicology, public health and biology in general.

The new study, says Skinner, provides a proof of concept that ancestral environmental exposures and environmental epigenetics promote ovarian disease and can be used to further diagnose exposure to toxicants and their subsequent health impacts. It also opens the door to using epigenetic molecular markers to diagnose ovarian disease before it occurs so new therapies could be developed.

In a broader sense, the study shows how epigenetics can have a significant role in disease development and life itself.

More information: doi: 10.1371/journal.pone.0036129

Provided by Washington State University search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Research identifies a way to make cancer cells more responsive to chemotherapy

Breast cancer characterized as "triple negative" carries a poor prognosis, with limited treatment options. In some cases, chemotherapy doesn't kill the cancer cells the way it's supposed to. New research from Western University ...

Cancer created 9 minutes ago | popularity not rated yet | comments 0

Mayo Clinic genomic analysis lends insight to prostate cancer

Mayo Clinic researchers have used next generation genomic analysis to determine that some of the more aggressive prostate cancer tumors have similar genetic origins, which may help in predicting cancer progression. The findings ...

Cancer created 13 minutes ago | popularity not rated yet | comments 0

When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs

Even while being dragged to its destruction inside a cell, a cancer-promoting growth factor receptor fires away, sending signals that thwart the development of tumor-suppressing microRNAs (miRNAs) before it's dissolved, researchers ...

Cancer created 1 hour ago | popularity not rated yet | comments 0 | with audio podcast

Improved chemo regimen for childhood leukemia may offer high survival, no added heart toxicity

Treating pediatric leukemia patients with a liposomal formulation of anthracycline-based chemotherapy at a more intense-than-standard dose during initial treatment may result in high survival rates without causing any added ...

Cancer created 5 hours ago | popularity not rated yet | comments 0

Protein preps cells to survive stress of cancer growth and chemotherapy

Scientists have uncovered a survival mechanism that occurs in breast cells that have just turned premalignant-cells on the cusp between normalcy and cancers-which may lead to new methods of stopping tumors.

Cancer created 5 hours ago | popularity not rated yet | comments 0 | with audio podcast


Shortage of key drug hampering U.S. efforts to control TB, report says

(HealthDay)—A shortage of a critical tuberculosis drug has hampered the efforts of health departments across the United States to contain the spread of the highly infectious lung disease, federal officials ...

Heart healthy lifestyle may cut kidney disease patients' risk of kidney failure

Maintaining a heart healthy lifestyle may also help protect chronic kidney disease patients from developing kidney failure and dying prematurely, according to a study appearing in an upcoming issue of the Journal of the Am ...

New microsphere-based methods for detecting HIV antibodies

Detection of HIV antibodies is used to diagnose HIV infection and monitor trials of experimental HIV/AIDS vaccines. New, more sensitive detection systems being developed use microspheres to capture HIV antibodies ...

It's not your imagination: Memory gets muddled at menopause

Don't doubt it when a woman harried by hot flashes says she's having a hard time remembering things. A new study published online in Menopause, the journal of The North American Menopause Society (NAMS), helps confirm with o ...

J&J expects 10-plus new drug applications by 2017

(AP)—Johnson & Johnson is developing what could eventually be game-changing treatments for depression and pain, and it's aiming to apply for approval of more than 10 new medicines by 2017, executives said Thursday during ...

Farm bill: Senate rejects GMO labeling amendment

The Senate has overwhelmingly rejected an amendment allowing states to require labeling of genetically modified foods.